Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Clinical and Translational Medicine, 2024
Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single‐arm, phase 2 prospective clinical trial

Man X., Huang J., Sun S. et al.

Olink Target 96OncologyPathophysiologyPlasma

JHLT Open, 2024
Proteomics early after heart transplantation and relation to coronary intimal changes and prognosis

Dalsgaard R., Clemmensen T., Eiskjær H. et al.

Olink Target 96CVDPatient StratificationPlasma

BMC Medicine, 2024
Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank

Wang X., Shi Z., Qiu Y. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

Clinical Immunology, 2024
Serum proteomics reveals hemophagocytic lymphohistiocytosis-like phenotype in a subset of patients with multisystem inflammatory syndrome in children

Tulling A., Holierhoek M., Jansen-Hoogendijk A. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesInfectious DiseasesPathophysiologyPatient StratificationSerum

PROTEOMICS – Clinical Applications, 2024
Methods and clinical biomarker discovery for targeted proteomics using Olink technology

Wang H., Zhao T., Zeng J. et al.

Wider Proteomics StudiesReview/editorial

Immunology & Cell Biology, 2024
Proteomics screening after pediatric allogenic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and cytomegalovirus reactivation

Alexandersson A., Venäläinen M., Heikkilä N. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma

Frontiers in Immunology, 2024
Plasma proteomics analysis of Chinese HIV-1 infected individuals focusing on the immune and inflammatory factors afford insight into the viral control mechanism

Ni W., Ren L., Liao L. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

BMJ Oncology, 2024
First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours

Naing A., Papadopoulos K., Pishvaian M. et al.

Olink Target 96OncologyPathophysiologyPlasma

Ticks and Tick-borne Diseases, 2024
Diagnostic patterns of serum inflammatory protein markers in children with Lyme neuroborreliosis

Fredriksson T., Brudin L., Henningsson A. et al.

Olink Target 96Infectious DiseasesPatient StratificationSerum

Biomolecules, 2024
GlycA and CRP Are Genetically Correlated: Insight into the Genetic Architecture of Inflammageing

Kasher M., Freidin M., Williams F. et al.

Olink Target 96Immunological & Inflammatory DiseasesAgingPathophysiologyBlood

Journal of the European Academy of Dermatology and Venereology, 2024
Exposure–response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis

Soenen R., Schots L., Wang Z. et al.

Olink Target 96Dermatological DiseasesPatient StratificationSerum

Clinical Immunology, 2024
Proteomic mapping identifies serum marker signatures associated with MIS-C specific hyperinflammation and cardiovascular manifestation

Reiter A., Verweyen E., Queste E. et al.

Olink Target 96Immunological & Inflammatory DiseasesInfectious DiseasesPathophysiologySerum

JCI Insight, 2024
Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans

Hellgren F., Rosdahl A., Arcoverde Cerveira R. et al.

Olink Target 96Infectious DiseasesPathophysiologyCell Culture Supernatant

Heart & Lung, 2024
Causal role of circulating inflammatory cytokines in cardiac diseases, structure and function

Ruan W., Zhou X., Liu H. et al.

Olink Target 96CVDPathophysiologyPlasma

Heliyon, 2024
Identification of endophenotypes supporting outcome prediction in hemodialysis patients based on mechanistic markers of statin treatment

Leierer J., Salib M., Evgeniou M. et al.

Olink Target 96CVDNephrologyPatient StratificationPlasma

Brain, Behavior, and Immunity, 2024
Plasma proteomic biomarkers and the association between poor cardiovascular health and incident dementia: The UK Biobank study

Beydoun M., Beydoun H., Hu Y. et al.

Olink Explore 3072/384CVDNeurologyPathophysiologyPlasma

Molecular & Cellular Proteomics, 2024
Pericyte-Specific Secretome Profiling in Hypoxia Using TurboID in a Multicellular in Vitro Spheroid Model

Enström A., Carlsson R., Buizza C. et al.

Olink Target 96NeurologyPathophysiologyTechnical EvaluationCell Culture Supernatant

Medicine, 2024
Exploring the casual association between gut microbiome, circulating inflammatory cytokines and chronic pancreatitis: A Mendelian randomization analysis

Yang X., Xu H., Liang X. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma

Cell Reports Medicine, 2024
Metabolic liability for weight gain in early adulthood

Murthy V., Mosley J., Perry A. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

International Journal of Molecular Sciences, 2024
Examination of the Complex Molecular Landscape in Obesity and Type 2 Diabetes

Vadadokhau U., Varga I., Káplár M. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPatient StratificationPlasma

1889 publications